We are live on ! Find out more
PBYI icon

Puma Biotechnology
PBYI

136 hedge funds and large institutions have $1.41B invested in Puma Biotechnology in 2017 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 45 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

84% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 19

41% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 32

32% more capital invested

Capital invested by funds: $1.07B → $1.41B (+$340M)

7.87% more ownership

Funds ownership: 94.87% → 102.74% (+7.9%)

6% more funds holding

Funds holding: 128 → 136 (+8)

9% less call options, than puts

Call options by funds: $16.8M | Put options by funds: $18.5M

Holders
136
Holders Change
+8
Holders Change %
+6.25%
% of All Funds
3.39%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
35
Increased
45
Reduced
32
Closed
19
Calls
$16.8M
Puts
$18.5M
Net Calls
-$1.71M
Net Calls Change
-$13M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$63.4M
2
PC
PointState Capital
New York
+$28.1M
3
CCM
Camber Capital Management
Massachusetts
+$23.7M
4
FCM
Farallon Capital Management
California
+$21.2M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.2M

Top Sellers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
-$33.7M
2
State Street
State Street
Massachusetts
-$16.3M
3
Morgan Stanley
Morgan Stanley
New York
-$16.2M
4
Citigroup
Citigroup
New York
-$5.22M
5
JP
Jana Partners
New York
-$4.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
126
Oppenheimer Asset Management
New York
$16K +$15.4K +423 New
LTFS
127
Ladenburg Thalmann Financial Services
Florida
$14K – – –
DADC
128
D.A. Davidson & Co
Montana
$9K – – –
MAM
129
Meeder Asset Management
Ohio
$7K -$11.8K -323 -64%
AWMS
130
Advocacy Wealth Management Services
Georgia
$7K – – –
Nisa Investment Advisors
131
Nisa Investment Advisors
Missouri
$6K -$5.11K -140 -47%
IWM
132
IHT Wealth Management
Illinois
$6K – – –
GXMC
133
Global X Management Company
New York
$6K +$219 +6 +4%
TRCT
134
Tower Research Capital (TRC)
New York
$3K -$240K -6,566 -99%
GT
135
Glenmede Trust
Pennsylvania
$3K – – –
AG
136
Advisor Group
Arizona
$1K -$18.2K -500 -94%
JP
137
Jana Partners
New York
– -$4.38M -142,727 Closed
SIM
138
Spark Investment Management
New York
– -$3.64M -118,700 Closed
HCM
139
Highbridge Capital Management
New York
– -$2.27M -73,864 Closed
Invesco
140
Invesco
Georgia
– -$1.59M -51,803 Closed
OAG
141
Orbis Allan Gray
Bermuda
– -$1.33M -43,493 Closed
NI
142
Numeric Investors
Massachusetts
– -$1.14M -37,200 Closed
ARTA
143
A.R.T. Advisors
New York
– -$779K -25,400 Closed
FRM
144
Fox Run Management
Connecticut
– -$654K -21,300 Closed
TI
145
Trexquant Investment
Connecticut
– -$593K -19,326 Closed
SCA
146
Secor Capital Advisors
New York
– -$545K -17,765 Closed
VRS
147
Virginia Retirement Systems
Virginia
– -$371K -12,100 Closed
ST
148
Spot Trading
Illinois
– -$292K -9,521 Closed
PA
149
Perceptive Advisors
New York
– -$225K -7,344 Closed
CSS
150
Cubist Systematic Strategies
Connecticut
– -$169K -5,521 Closed
3 4 5
6
7

PBYI Hedge Fund Activity: Q1 2017 in Review

136 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Puma Biotechnology (PBYI) for Q1 2017, worth a combined $1.41B — up 32% from $1.07B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new PBYI positions and 19 closed out — a net gain of 16 holders — while 45 added to existing stakes and 32 trimmed.

The largest buyer was BlackRock, adding an estimated $63.4M. The largest seller was American Century Companies, cutting an estimated $33.7M.

  • 136 institutional investors held Puma Biotechnology (PBYI) as of Q1 2017, up from 128 in Q4 2016.
  • Funds reported $1.41B of Puma Biotechnology stock for Q1 2017, up 32% quarter-over-quarter.
  • 35 funds opened new Puma Biotechnology positions in Q1 2017 and 19 closed out, a net change of +16 holders.
  • The largest Puma Biotechnology buyer in Q1 2017 was BlackRock, an estimated $63.4M added.
  • The largest Puma Biotechnology seller in Q1 2017 was American Century Companies, an estimated $33.7M sold.

Based on aggregated 13F filings for Q1 2017.